Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 54(11): 3854-65, 2011 Jun 09.
Article in English | MEDLINE | ID: mdl-21545152

ABSTRACT

Phage panning led to the discovery of a disulfide-cyclized peptide CRYPEVEIC that inhibits Pin1 activity with a K(I) of 0.5 µM. NMR chemical shift perturbation experiments show that cyclic CRYPEVEIC binds to the active site of Pin1. Pin1 residues K63 and R68, which bind the phosphate of substrate peptides, do not show a significant chemical shift change in response to binding of cyclic CRYPEVEIC, consistent with absence of phosphate on the peptide. Cyclic CRYPEVEIC adopts a stable conformation with the side chains of the Y, P, V, and I residues packed together on one side of the ring. Cyclic CRYPEVEIC in solution exists as a mixture of two species, with a 1:4 cis/trans ratio for the Y-P bond. This mixture is stabilized to a single conformation when bound to Pin1. The constrained structure of cyclic CRYPEVEIC apparently facilitates high affinity binding without the presence of a phosphate group.


Subject(s)
Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , Peptide Library , Peptides, Cyclic/chemical synthesis , Peptides, Cyclic/pharmacology , Peptidylprolyl Isomerase/antagonists & inhibitors , Peptidylprolyl Isomerase/metabolism , Binding Sites , Catalytic Domain , Drug Discovery , Enzyme Inhibitors/chemistry , Molecular Structure , Molecular Targeted Therapy , NIMA-Interacting Peptidylprolyl Isomerase , Peptides, Cyclic/chemistry , Peptidylprolyl Isomerase/chemistry , Phosphorylation , Protein Binding , Protein Conformation , Substrate Specificity
2.
J Bacteriol ; 189(24): 9057-65, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17933889

ABSTRACT

Burkholderia cenocepacia is a gram-negative opportunistic pathogen that belongs to the Burkholderia cepacia complex. B. cenocepacia can survive intracellularly within phagocytic cells, and some epidemic strains produce a brown melanin-like pigment that can scavenge free radicals, resulting in the attenuation of the host cell oxidative burst. In this work, we demonstrate that the brown pigment produced by B. cenocepacia C5424 is synthesized from a homogentisate (HGA) precursor. The disruption of BCAL0207 (hppD) by insertional inactivation resulted in loss of pigmentation. Steady-state kinetic analysis of the BCAL0207 gene product demonstrated that it has 4-hydroxyphenylpyruvic acid dioxygenase (HppD) activity. Pigmentation could be restored by complementation providing hppD in trans. The hppD mutant was resistant to paraquat challenge but sensitive to H2O2 and to extracellularly generated superoxide anions. Infection experiments in RAW 264.7 murine macrophages showed that the nonpigmented bacteria colocalized in a dextran-positive vacuole, suggesting that they are being trafficked to the lysosome. In contrast, the wild-type strain did not localize with dextran. Colocalization of the nonpigmented strain with dextran was reduced in the presence of the NADPH oxidase inhibitor diphenyleneiodonium, and also the inducible nitric oxide inhibitor aminoguanidine. Together, these observations suggest that the brown pigment produced by B. cenocepacia C5424 is a pyomelanin synthesized from an HGA intermediate that is capable of protecting the organism from in vitro and in vivo sources of oxidative stress.


Subject(s)
4-Hydroxyphenylpyruvate Dioxygenase/metabolism , Antioxidants/metabolism , Burkholderia cepacia complex/enzymology , Homogentisic Acid/metabolism , Melanins/biosynthesis , 4-Hydroxyphenylpyruvate Dioxygenase/genetics , Animals , Anti-Bacterial Agents/pharmacology , Burkholderia cepacia complex/drug effects , Burkholderia cepacia complex/genetics , Cell Line , Drug Resistance, Bacterial/physiology , Gene Deletion , Genes, Bacterial , Genetic Complementation Test , Hydrogen Peroxide/pharmacology , Lysosomes/microbiology , Macrophages/microbiology , Melanins/genetics , Mice , Mutagenesis, Insertional , Oxidants/pharmacology , Paraquat/pharmacology , Superoxides/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...